An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer
Key facts
- Who runs it
- Thomas Jefferson University
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 1 person enrolled
- Started
- 13 Dec 2023
- Ended
- 29 Oct 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Behavioral Dietary Intervention
- Text Message-Based Navigation Intervention
- Internet-Based Intervention
- Dietary Counseling and Surveillance
- Stereotactic Radiosurgery
- Biospecimen Collection
- Magnetic Resonance Imaging
- Neurocognitive Assessment
- Questionnaire Administration
- Interview
- Record updated
- 3 March 2026
- Why it stopped
- slow accrual
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Age 18 years or older
- Pathologically proven breast or lung cancer primary malignancy confirmed
- Body mass index (BMI) ≥ 25 kg/m\^2
- SRS candidate (1-10 MRI detected brain metastases as per the discretion of radiologist) as determined by the treating physician
- Chemotherapy, hormone, and immune therapy will be allowed concurrently
- Willing and able to comply with the protocol for the duration of the study
- Able to speak, read and write English
- Negative pregnancy test if childbearing potential
- Owns a mobile phone with mobile text messaging (TXT) capability
Who cannot take part
- Prior brain surgery ≤ 14 days prior to enrollment
- Inability to tolerate a normal diet (may include an active malabsorption syndrome at the time of consent [i.e. Crohn's disease, major bowel resection leading to permanent malabsorption])
- Intractable seizures while on adequate anticonvulsant therapy-more than 1 seizure per week for the past 2 months
- Not a SRS candidate as determined by the treating physician
- Patient with a diagnosis of glioma, or other World Health Organization (WHO) grade II-IV primary brain tumor
Where in United States
- Sidney Kimmel Cancer Center at Thomas Jefferson UniversityPhiladelphia, United States
About the trial
What the trial wants to find out
This clinical trial tests the effectiveness of an interactive time-restricted diet intervention (txt4fasting) in reducing neurocognitive decline and improving survival outcomes after stereotactic radiosurgery in patients with breast or lung cancer that has spread to the brain (brain metastases). Lung cancer and breast cancer are the two most frequent causes of brain metastases. The diagnosis of brain metastases is associated with poorer survival and tumor-induced and treatment-related side effects. Stereotactic radiosurgery is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. Patients who receive stereotactic radiosurgery for brain metastases may experience less neurocognitive side effects than with other types of brain radiation, but may still be at risk for their brain metastases growing, spreading, or getting worse. Patients with obesity and diabetes have been shown to have worse survival and increased radiation-related side effects. Evidence demonstrates that simply changing meal timing can have a positive impact on multiple health outcomes. Time-restricted eating, or prolonged nighttime fasting, has been proven to have positive effects on heart disease risk reduction, weight control management and chemotherapy side effect reduction. Txt4fasting may be effective in decreasing neurocognitive decline and improving survival outcomes in patients undergoing stereotactic radiosurgery for brain metastases from breast or lung cancer.
The 2 groups in the trial
- Arm I (txt4fasting)Treatment being tested
Patients follow a time-restricted diet, receive interactive positive reinforcement messages, and record food intake using the txt4fasting platform daily for 30 days. Patients receive counseling calls twice weekly in weeks 1 and 2 then once weekly in weeks 3 and 4. Patients then undergo SRS on study. Patients also undergo blood sample collection and brain MRI throughout study.
Treatment: Behavioral Dietary Intervention, Text Message-Based Navigation Intervention, Internet-Based Intervention, Dietary Counseling and Surveillance, Stereotactic Radiosurgery, Biospecimen Collection, Magnetic Resonance Imaging, Neurocognitive Assessment, Questionnaire Administration, and Interview
- Arm II (attention control)Existing treatment, for comparison
Patients receive text messages about healthy eating habits and food suggestions twice daily and record food intake using txt4fasting program for 30 days. Patients then undergo SRS on study. Patients also undergo blood sample collection and brain MRI throughout study.
Treatment: Internet-Based Intervention, Stereotactic Radiosurgery, Text Message-Based Navigation Intervention, Biospecimen Collection, Magnetic Resonance Imaging, Neurocognitive Assessment, Questionnaire Administration, and Interview
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Txt4fasting: An Interactive Mobile Time-Restricted Eating Diet Intervention for Patients With Brain Metastases to Maximize Radiation Outcomes
- Record updated
- 3 March 2026